INS and type 2 diabetes mellitus: Novel therapeutic strategies for T2DM are exploring strategies, such as direct insulin secretion stimulation, leveraging the incretin axis, hepatic glucose production suppression, and enhanced insulin sensitivity to tailor glycemic control for each patient while ensuring safety and preventing complications [60, 61].